Avoiding Regulatory Trouble & Responding to Government Inquiries: Anti-Fraud & FDA Update for Manufacturers

Hosted By: Fredrikson & Byron’s White Collar & Regulatory Defense Group and Gardner Law


  • Brent Eilefson, Vice President, Legal Affairs, Chief Compliance Officer and Corporate Secretary, Upsher-Smith Laboratories
  • Dulce Foster, Shareholder, Fredrikson & Byron
  • Mark Gardner, Directing Attorney, Gardner Law
  • Mary Heath, Associate, Fredrikson & Byron (Moderator)
  • Amanda Johnston, Managing Attorney, Gardner Law
  • Sarah Karlgaard, General Counsel, Canon Medical Systems Corporation, HIT Division
  • Anne Miller, Principal Legal Counsel, Medtronic
  • Sandra Sedo, Chief Compliance Officer, Cardiovascular Systems, Inc. (CSI)

Program Description:

On October 14, 2021, Fredrikson & Byron’s White Collar & Regulatory Defense Group and Gardner Law presented a half-day webinar on:

  • the latest anti-fraud and FDA cases;
  • what it takes to design and maintain an effective compliance program and perform investigations; and
  • how to respond to a government investigation.

The program consisted of six sessions. Click the title to be taken to a video of the recording.

Recent FDA, AKS and FCA Cases

Impact of Recent Cases and OIG Guidance

Deploying a Compliance Program & Performing Investigations

Managing Compliance

Responding to a Government Investigation

FDA Enforcement

Questions:         events@fredlaw.com